Healio Minute Podcast, Neurology Edition: Top Headlines - Week of October 24, 2022
In this edition, headache characteristics to classify as migraine; FDA grants breakthrough device designation; engineering company to develop neuroactive compounds from plants and more.
Read the full coverage here:
Evaluate headache characteristics to classify as migraine
FDA grants breakthrough device designation for brain implant technology
New genetic engineering company aims to develop neuroactive compounds from plants, fungi
Angiotensin receptor blocker therapy associated with decreased incidence of epilepsy
Theranica announces positive results from clinical trial for migraine treatment device
References:
Diamond M. Migraine, chronic migraine and medication overuse headache: Where are we today? Presented at: PAINWeek; Sept. 6-9, 2022; Las Vegas
Doege C, et al. JAMA Neurol. 2022;doi:10.1001/jamaneurol.2022.3413.
Collapse
